Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Metabolic

Oncology

Respiratory

Inflammation
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

Glyxambi
CV Risk Protection
Tools & Apps
5 years of EMPA-REG Outcome
Let's Talk
Prof Christoph Wanner’s take on EMPA-KIDNEY
Prescribing Information
Voice of CRM
Videos

IN THE MANAGEMENT OF TYPE 2 DIABETES^*1

EASY CHOICE FOR YOUR
TYPE 2 DIABETES PATIENTS

Glyxambi: 1 Pill 10 Benefits

Author: Boehringer Ingelheim

Document ID: PC-SG-102796

Home
Metabolic
Empagliflozin
When Time Meets Power
Glyxambi: 1 Pill 10 Benefits

Sitemap

Therapeutic Area

Resources

BI logo

Privacy
Terms of use
Sitemap
Contact

This website is intended for healthcare professionals in Singapore. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.

EASY CHOICE FOR YOURTYPE 2 DIABETES PATIENTS

Glyxambi: 1 Pill 10 Benefits

EASY CHOICE FOR YOUR
TYPE 2 DIABETES PATIENTS